For this patient, who presented with a stage IV lymphoma and a leukemic presentation, the examination of the gene expression values showed that the genes of the GCB signature and BCL2 were highly expressed in the tumor, suggesting a high tumor/microenvironment ratio and further pointing to the need for a rigorous initial histological evaluation for classification. The gene discussed is BCL2; the disease is lymphoma.